Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study.

MLA

Bailly-Caillé, Barbara, et al. “Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): A Retrospective Cohort Study.” Cancers, vol. 15, no. 2, Jan. 2023, p. 495. EBSCOhost, https://doi.org/10.3390/cancers15020495.

APA

Bailly-Caillé, B., Kottler, D., Morello, R., Lecornu, M., Kao, W., Meyer, E., Dompmartin, A., & L’Orphelin, J.-M. (2023). Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study. Cancers, 15(2), 495. https://doi.org/10.3390/cancers15020495

Chicago

Bailly-Caillé, Barbara, Diane Kottler, Rémy Morello, Marie Lecornu, William Kao, Emmanuel Meyer, Anne Dompmartin, and Jean-Matthieu L’Orphelin. 2023. “Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): A Retrospective Cohort Study.” Cancers 15 (2): 495. doi:10.3390/cancers15020495.